874 related articles for article (PubMed ID: 17289886)
41. Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
Cristofanilli M
Semin Oncol; 2006 Jun; 33(3 Suppl 9):S9-14. PubMed ID: 16797376
[TBL] [Abstract][Full Text] [Related]
42. Is there a role for circulating tumor cells in the management of breast cancer?
Hayes DF; Smerage J
Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
[TBL] [Abstract][Full Text] [Related]
43. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
Mostert B; Sleijfer S; Foekens JA; Gratama JW
Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
[TBL] [Abstract][Full Text] [Related]
45. The biological information obtainable from circulating tumor cells.
Cristofanilli M
Breast; 2009 Oct; 18 Suppl 3():S38-40. PubMed ID: 19914540
[TBL] [Abstract][Full Text] [Related]
46. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
[TBL] [Abstract][Full Text] [Related]
48. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
[TBL] [Abstract][Full Text] [Related]
49. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer.
Sato N; Hayashi N; Imamura Y; Tanaka Y; Kinoshita K; Kurashige J; Saito S; Karashima R; Hirashima K; Nagai Y; Miyamoto Y; Iwatsuki M; Baba Y; Watanabe M; Baba H
Ann Surg Oncol; 2012 Jun; 19(6):2060-5. PubMed ID: 21732137
[TBL] [Abstract][Full Text] [Related]
50. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
51. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
52. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
53. Image cytometry analysis of circulating tumor cells.
Lowes LE; Goodale D; Keeney M; Allan AL
Methods Cell Biol; 2011; 102():261-90. PubMed ID: 21704842
[TBL] [Abstract][Full Text] [Related]
54. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
[TBL] [Abstract][Full Text] [Related]
55. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility.
Liu Z; Jiang M; Zhao J; Ju H
Clin Cancer Res; 2007 May; 13(10):2992-7. PubMed ID: 17505001
[TBL] [Abstract][Full Text] [Related]
56. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
Kurihara T; Itoi T; Sofuni A; Itokawa F; Tsuchiya T; Tsuji S; Ishii K; Ikeuchi N; Tsuchida A; Kasuya K; Kawai T; Sakai Y; Moriyasu F
J Hepatobiliary Pancreat Surg; 2008; 15(2):189-95. PubMed ID: 18392713
[TBL] [Abstract][Full Text] [Related]
57. Circulating and disseminated tumor cells in the management of breast cancer.
Ross JS; Slodkowska EA
Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
[TBL] [Abstract][Full Text] [Related]
58. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
[TBL] [Abstract][Full Text] [Related]
59. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
60. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
Hartkopf AD; Wagner P; Wallwiener D; Fehm T; Rothmund R
Anticancer Res; 2011 Mar; 31(3):979-84. PubMed ID: 21498725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]